期刊文献+

睡眠鼾症患者血清内皮素和一氧化氮测定及其临床意义 被引量:1

Clinical significance of plasma Endothelin and Nitric Oxide in snoring patients
在线阅读 下载PDF
导出
摘要 目的探讨阻塞性睡眠呼吸暂停低通气综合征(OSAHS)患者血清内皮素(ET)、一氧化氮(NO)与高血压的关系。方法检测150例睡眠鼾症患者血清ET和NO水平,ET采用放射免疫法测定,NO采用硝酸还原酸法测定。结果轻度(n=53)、中度(n=21)、重度(n=20)OSAHS患者血清ET分别为(47±25)、(60±21)、(52±22)pg?ml,血清NO分别为(63±8)、(63±10)、(54±17)μmol?L。不同程度的OSAHS患者间血清ET差别无显著性意义(F=0.931,P>0.05);重度OSAHS患者血清NO降低(F=2.361,P<0.05),舒张压增高(F=3.520,P<0.05);但重度OSAHS伴与不伴高血压患者的血NO水平差别无显著性意义(F=-0.757,P>0.05)。结论重度OSAHS患者血清NO降低,舒张压增高,血ET和NO在OSAHS中引起高血压的作用可能不大。 Objective To explore the relationship between Endothelin(ET), Nitric Oxide(NO)in obstructive sleep apnea-hypopnea syndrome (OSAHS) and hypertension. Methods To detect plasma ET and NO in 150 snoring patients with radioimmunity assay and nitric acid deoxidize assay severalty. Results Plasma ET and NO are(47±25)?(60±21)?(52±22)pgml and (63±8 )?(63±10) ?(54±17) μmolL respectively in light (n=53), moderate (n=21), heavy (n=20) groups. There is no significant difference for ET in variable OSAHS. There are marked descent for NO in heavy OSAHS(F=2.361,P<0.05). Diastolic pressure is higher in this group(F=3.520,P<0.05). But there is no statistical difference in heavy OSAHS with or without hypertension(F=-0.757,P>0.05). Conclusion There are lower NO and higher diastolic pressure in heavy OSAHS. ET and NO are probably not necessary in OSAHS with hypertension.
出处 《浙江医学》 CAS 2005年第3期178-179,182,共3页 Zhejiang Medical Journal
关键词 患者 OSAHS ET 血清内皮素 重度 鼾症 睡眠 显著性 目的 程度 Snoring Endothelin Nitric Oxide
  • 相关文献

参考文献12

  • 1刘国仗.高血压的诊断与分类[J].中华内科杂志,1999,38(8):572-573. 被引量:67
  • 2中华医学会呼吸病学分会睡眠呼吸疾病学组.阻塞性睡眠呼吸暂停低通气综合征诊治指南(草案)[J].中华结核和呼吸杂志,2002,25(4):195-198. 被引量:1847
  • 3Hedner J. Regulation of systemic vasculature in obstructive sleep apnea syndrome. Sleep, 2000, 23(1): 132.
  • 4Kales A, Cadieux R J, Shaw LC, et al. Sleep apnea in a hypertensive population. Lancet, 1984, 323(2): 1005.
  • 5Fletcher EC, DeBehnke RD, Lovoi MS, et al. Undiagnosed sleep apnea in patients with essential hypertension. Ann Intern Med, 1985, 103(2):190.
  • 6Lavie P, Ben-yosef R, Rubin AE. Prevalence of sleep apnea syndrome among patients with essential hypertension. Am Heart J, 1984, 108(2):373.
  • 7Williams AJ, Houston D, Finberg S, et al. Sleep apnea syndromes and essential hypertension. Am J Cardiol, 1985, 55(8):1019.
  • 8Fletcher EC. Cardiovascular consequences of obstructive sleep apnea: experimental hypoxia and sympathetic activity. Sleep,2000, 23(S4): S127.
  • 9Phillips BG. Effects of obstructive sleep apnea syndrome on endothelin-1 and blood pressure. J Hypertension, 1999, 17(1):61.
  • 10Grimpen F, Endothelin plasma levels are not elevated in patients with obstructive sleep apnea. Eur Respir J, 2000, 15(2):320.

共引文献1912

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部